Trajectory of skeletal muscle index (SMI) loss during palliative systemic treatment (Tx) predicts time to progression (TTP) in metastatic colorectal cancer (mCRC) patients
Sophie A. Kurk(Utrecht University), Anne M. May(Utrecht University), Miriam Koopman(Utrecht University), Rebecca K. Stellato(University Medical Center Utrecht), Marieke J Oskam(Maastricht University Medical Centre), Petra H.M. Peeters(University Medical Center Utrecht), Bram Dorresteijn(Nutricia Research (Netherlands)), Marion Jourdan(Nutricia Research (Netherlands)), Cornelis J.A. Punt(Utrecht University)
Cited by 0
Related Papers
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Direct detection of early-stage cancers using circulating tumor DNA
|Science Translational Medicine|2017|1.1k